AstraZeneca
AZN
$67.94
Share price
-0.41%
Change (1 day)
4.01%
Change (1 year)
Categories
AstraZeneca (AZN) - Net assets
Net assets on the balance sheet as of June 2023 : $37.41 B
According to AstraZeneca's latest financial reports the company has $37.41 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AstraZeneca - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $37.05 B | -5.67% |
| 2021-12-31 | $39.28 B | 151.23% |
| 2020-12-31 | $15.63 B | 7.14% |
| 2019-12-31 | $14.59 B | 3.93% |
| 2018-12-31 | $14.04 B | -15.61% |
| 2017-12-31 | $16.64 B | -0.16% |
| 2016-12-31 | $16.66 B | -9.94% |
| 2015-12-31 | $18.50 B | -5.79% |
| 2014-12-31 | $19.64 B | -15.51% |
| 2013-12-31 | $23.25 B | -2.92% |
| 2012-12-31 | $23.95 B | 2.04% |
| 2011-12-31 | $23.47 B | 0.26% |
| 2010-12-31 | $23.41 B | 12.43% |
| 2009-12-31 | $20.82 B | 29.65% |
| 2008-12-31 | $16.06 B | 7.68% |
| 2007-12-31 | $14.91 B | -3.25% |
| 2006-12-31 | $15.41 B | 12.6% |
| 2005-12-31 | $13.69 B | -5.56% |
| 2004-12-31 | $14.49 B | 9.35% |
| 2003-12-31 | $13.25 B | 18.03% |
| 2002-12-31 | $11.23 B | -18.39% |
| 2001-12-31 | $13.76 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.86 B | 89.41% | 🇺🇸 USA |
 Novartis NVS | $51.93 B | 38.79% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.23 B | 170.57% | 🇺🇸 USA |
 Abbott Laboratories ABT | $37.23 B | -0.49% | 🇺🇸 USA |
 Eli Lilly LLY | $11.14 B | -70.20% | 🇺🇸 USA |
 Sanofi SNY | $79.27 B | 111.89% | 🇫🇷 France |
 Biogen BIIB | $14.46 B | -61.35% | 🇺🇸 USA |
 Merck MRK | $46.90 B | 25.36% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $32.03 B | -14.39% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.33 B | -59.01% | 🇬🇧 UK |